(Q42495011)

1 November 2017

title

Antioxidant pyruvate inhibits cardiac formation of reactive oxygen species through changes in redox state (English)

1 reference

1 November 2017

main subject

reactive oxygen species

1 reference

Bassenge E

1

1 reference

1 November 2017

Sommer O

series ordinal

2

1 reference

1 November 2017

Schwemmer M

series ordinal

3

1 reference

1 November 2017

Bünger R

series ordinal

4

1 reference

1 November 2017

publication date

1 November 2000

1 reference

American Journal of Physiology Heart and Circulatory Physiology

1 November 2017

published in

1 reference

1 November 2017

volume

279

1 reference

1 November 2017

issue

5

1 reference

1 November 2017

page(s)

H2431-8

1 reference

Compartmented pyruvate in perfused working heart.

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.5.H2431

Mitochondrial pyruvate transport in working guinea-pig heart. Work-related vs. carrier-mediated control of pyruvate oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.5.H2431

Pyruvate-enhanced phosphorylation potential and inotropism in normoxic and postischemic isolated working heart. Near-complete prevention of reperfusion contractile failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.5.H2431

Protection by pyruvate against inhibition of Na+, K(+)-ATPase by a free radical generating system containing t-butylhydroperoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.5.H2431

The influence of lactate, pyruvate and glucose as exogenous substrates on free radical defense mechanisms in isolated rat hearts during ischaemia and reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.5.H2431

Haemodynamic effects of intracoronary pyruvate in patients with congestive heart failure: an open study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.5.H2431

Coronary autoregulation and purine release in normoxic heart at various cytoplasmic phosphorylation potentials: disparate effects of adenosine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.5.H2431

Effects of treatment with pyruvate and tromethamine in experimental myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.5.H2431

Energetic modulation of cardiac inotropism and sarcoplasmic reticular Ca2+ uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.5.H2431

Mitochondrial metabolism of pyruvate is required for its enhancement of cardiac function and energetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.5.H2431

Lactate and PO2 modulate superoxide anion production in bovine cardiac myocytes: potential role of NADH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.5.H2431

Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.5.H2431

Secretion of pyruvate. An antioxidant defense of mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.5.H2431

10.1152/AJPHEART.2000.279.5.H2431

21 January 2018

Identifiers

DOI

0 references

1 reference